NASDAQ$BTTC

Black Titan Corp · Q2 2017 earnings

Q2 2017 earnings · · Investor relations

Headline financials

Total Revenue

$77K

Previous: $15M-99.5%
EPS (adj)

-$612.00

No prior period
Free Cash Flow

-$2.52M

No prior period
Net Income

-$3.45M

Previous: $11.9M-128.9%
Operating Income

-$3.62M

Previous: $12M-130.1%
Gross Profit

-$2.42M

Previous: $13.3M-118.3%
Cash & Equivalents

$8.35M

Previous: $19.3M-56.7%
Total Assets

$9.41M

Previous: $25.3M-62.8%
Stock-Based Comp

$382K

Previous: $249K+53.4%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$77K

Q2 2017-99.5%vs Q2 2016
Beat estimate in 8 of 13 quarters(62%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro